News Image

Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors

Provided By GlobeNewswire

Last update: Jul 9, 2025

Veteran clinical leader with successful track record and experience to help guide the Company’s clinical strategy in Fibrostenotic Crohn’s Disease and Ulcerative Colitis

Read more at globenewswire.com

PALISADE BIO INC

NASDAQ:PALI (8/6/2025, 4:58:10 PM)

After market: 0.9899 -0.01 (-1.01%)

1

-0.02 (-1.96%)



Find more stocks in the Stock Screener

PALI Latest News and Analysis

Follow ChartMill for more